Hashkey Grant Application

[MeowMotion]

Grant Type

Session 1

Email

[email protected]

Telegram

@Mike_Blumming

X/Twitter Handle

@celdataofficial

Discord/Community

https://t.me/CelData

Previous Application

N/A

Code Audit

N/A

Project Information

1. Project Description:
   CelData is a decentralized data network purpose-built for the life sciences industry. Developed by the Cel Group, it leverages blockchain, decentralized storage, and privacy-preserving computing technologies to enable secure, efficient, and transparent sharing of scientific data. CelData aims to address long-standing issues in the traditional research ecosystem, such as data silos, lack of transparency, and inefficient collaboration.
   By providing infrastructure that ensures data authenticity, traceability, and privacy, CelData empowers researchers, institutions, and biotech companies to collaborate seamlessly on a global scale.

Key Objectives:

1. Democratize Scientific Research: Lower entry barriers by enabling fair access to data, resources, and funding through a decentralized model.
2. Foster Open Collaboration: Build a transparent and trustless ecosystem where data and results are openly accessible, accelerating scientific progress.
3. Ensure Data Security and Privacy: Utilize decentralized storage (e.g., IPFS), privacy-preserving computing, and DID to protect sensitive life sciences data.
4. Incentivize Contribution: Reward data providers, researchers, and participants with native tokens to encourage data sharing and active engagement.
5. Drive Innovation in Life Sciences: Support applications in genomics, drug development, stem cell research, and cross-border scientific collaboration.

2. Success Potential:
   CelData is well-positioned for success due to a strong alignment with emerging trends in scientific research and Web3 technologies. Its potential stems from three key pillars: market demand, technical feasibility, and team capability.

1. Market Demand
   Growing Need for Data Transparency & Security in Life Sciences:

• As the life sciences industry increasingly relies on data-driven methods such as AI-driven drug discovery, genomics, and personalized medicine, there is a pressing need for platforms that ensure data authenticity, security, and compliance.
• DeSci and Web3 Momentum:
  The decentralized science (DeSci) movement is gaining traction as researchers seek alternatives to centralized institutions. CelData’s open and democratized model fits perfectly with this global shift.
• Global Collaboration Needs:
  Research is becoming more global and interdisciplinary. CelData addresses the pain points of cross-border data sharing, privacy compliance, and trust building between institutions.

2. Technical Feasibility

• Proven Technologies:
  CelData integrates mature and scalable technologies such as IPFS for decentralized storage, DID for identity management, and privacy-preserving computing methods like federated learning and MPC to ensure confidentiality.
• On-chain Data and Incentive Model:
  The use of blockchain ensures full traceability and transparency of data usage and contributions, while native token incentives drive community engagement and ecosystem growth.
• Modular Infrastructure:
  Its architecture supports multiple scientific scenarios including genomics, stem cell research, and drug development, making it adaptable to the diverse needs of the life sciences sector.

3. Team Capability

• World-Class Scientific Leadership:
  The project is backed by a research team from top-tier institutions such as Stanford, Harvard, and USC, including Nobel Prize winner Prof. Thomas C. Südhof.
• Industry Expertise & Medical Network:
  The core medical team has decades of clinical and biotherapeutic experience, with deep roots in both Western and traditional Chinese medicine, enabling strategic partnerships and early adoption.
• Operational & Strategic Strength:
  With a strong foundation in both Web3 development and biomedical commercialization, the team is capable of executing complex R&D tasks and large-scale collaborations.

3. Mission Alignment:
   CelData’s mission to revolutionize life sciences research through decentralization is closely aligned with HashKey’s core goals in the Web3 ecosystem—infrastructure innovation, real-world adoption, and long-term value creation.

1. Web3 Infrastructure Innovation
   HashKey supports foundational Web3 projects that offer robust, scalable, and impactful infrastructure.
   CelData is precisely such a project—it provides the decentralized data infrastructure needed for scientific research, incorporating:

• Decentralized storage and data flow (via IPFS and privacy-preserving computing)
• On-chain identity and access control (via DIDs)
• Smart contract–based incentive and governance systems

This positions CelData as a building block for future Web3 use cases in health, biotech, and scientific data monetization.

2. Real-World Adoption & Utility
   CelData brings Web3 technology directly into the life sciences sector, addressing:

• Genuine industry pain points such as data silos, IP protection, and collaboration inefficiencies
• Practical scenarios in genomics, drug development, and stem cell research
• High adoption potential among institutions, researchers, and biotech firms

This bridges the gap between blockchain infrastructure and real-world scientific and healthcare systems.

3. Sustainable Ecosystem Growth
   CelData is designed with:

• A tokenomic model that rewards participation and aligns stakeholder interests
• Governance mechanisms that empower the community and ensure decentralized decision-making
• Ecosystem partnerships with universities, hospitals, and research centers to drive organic expansion
  Together, these principles ensure that CelData will not only launch successfully but will evolve as a long-term contributor to the Web3 and DeSci ecosystems.

4. Innovation:
   CelData stands out as a trailblazer in both the DeSci and Web3 infrastructure spaces by introducing purpose-built, privacy-first, and incentive-aligned data solutions for the life sciences sector. Its innovation lies in the way it bridges cutting-edge blockchain technology with the real-world needs of biomedical research.

1. Purpose-Built for Life Sciences
   Unlike general-purpose data networks, CelData is specifically designed for the complexities of life sciences:

• Handles large-scale, high-sensitivity data like genomic sequences and clinical trial results
• Integrates computational biology workflows into decentralized environments
• Offers application-specific modules for drug development, stem cell research, and global scientific collaboration

This vertical focus gives CelData a significant edge in usability, adoption, and impact.

2. Privacy-Preserving Data Sharing
   CelData innovatively combines:

• Decentralized Storage (IPFS): Enables secure, tamper-proof data hosting
• Privacy Computing (MPC & Federated Learning): Allows researchers to collaborate without exposing raw data
• DID-based Access Control: Assigns unique on-chain IDs to institutions and scientists, facilitating verifiable, trusted collaborations

These layered technologies enable secure, compliant data use—critical for health-related research.

3. On-Chain Contribution Tracking & Incentives
   CelData introduces a novel data empowerment model where:

• Every data contribution, usage, and update is recorded on-chain
• Contributors (whether researchers, data owners, or institutions) are transparently rewarded in native tokens
• This creates a “data-to-value” flywheel, incentivizing continuous input, sharing, and collaboration

It’s not just a tool—it’s an economic system designed to unlock and sustain scientific innovation.

4. Scientific Legitimacy + Web3 Synergy
   CelData uniquely combines a world-class scientific foundation (with Nobel-level advisors and clinical research veterans) and a native Web3 architecture. This dual strength allows the project to:

• Be trusted by scientific institutions
• Be scalable in decentralized networks
• Be interoperable with other DeSci and Web3 ecosystems

5. Is it open source?
   Yes

6. Free or fee-based for end users?
   CelData adopts a hybrid model that balances open access with value-driven sustainability:

1. Free Access for Public and Academic Users
   Researchers, academic institutions, and nonprofit contributors can access core platform services such as:

• Open scientific data (with permission from data owners)
• Basic decentralized identity (DID) registration
• Participation in community governance
• This supports CelData’s mission of democratizing science and promoting global collaboration.

2. Fee-Based Services for Enterprise and Advanced Usage
   Commercial entities (e.g., pharmaceutical companies, biotech startups) and high-volume users may pay fees for:

• Advanced computing services (e.g., federated model training, AI simulations)
• Priority data access and storage capacity
• Premium features like private datasets, analytics dashboards, and API integrations
• Payments will be made in the native $CEL token, aligning usage with the platform’s tokenomics and incentivizing ecosystem growth.

3. Token-Based Incentives
   Users contributing valuable data or computation resources will be rewarded in tokens.
   Fee-paying users effectively sustain the system by contributing to the reward pool—creating a circular, community-driven economy.

7. Interoperability with Hashkey ecosystem:
   CelData is designed to be highly interoperable with leading Web3 infrastructures, and aligns well with multiple components of the HashKey ecosystem, both in technology and community engagement. Here’s how:

1. Blockchain Compatibility & Infrastructure Synergy
   CelData can integrate seamlessly with HashKey-supported Layer 1 & Layer 2 chains, especially those optimized for data security, compliance, and scalability.
   It can utilize HashKey’s on-chain compliance tools and identity frameworks to meet regulatory requirements—especially crucial in life sciences data handling.

2. Token & Wallet Integration
   The native $CEL token can be made compatible with HashKey’s wallet infrastructure and listed on HashKey Exchange, improving liquidity and utility.
   End users will be able to store, stake, and transact $CEL using secure tools within HashKey’s DeFi and CeFi ecosystem.

3. Research & Enterprise Collaboration
   Through HashKey’s enterprise and institutional network, CelData can expand adoption among biotech firms, hospitals, and scientific institutions.
   Joint initiatives (e.g., co-hosted DeSci events, accelerator programs) can foster real-world collaborations, especially in Hong Kong and Asia-Pacific.

4. Knowledge and Community Integration
   CelData can collaborate with HashKey Capital’s portfolio of DeSci, infrastructure, and AI-related projects for cross-project synergies.
   HashKey’s community hubs (such as online forums, research DAO initiatives) offer CelData a ready user base of forward-looking researchers and builders.

Market Analysis

1. Competitors and Differentiation:

CelData’s Differentiation & Competitive Edge

1. Life Sciences–Specific Infrastructure
   CelData isn’t a general-purpose data protocol—it is custom-built for life sciences applications, including genomics, drug discovery, stem cell research, and biomedical collaboration.
2. Full-Stack Decentralization

• Combines data storage (IPFS), privacy-preserving computing (MPC/Federated Learning), decentralized identity (DID), and on-chain incentive mechanisms into a cohesive platform.
• This offers a one-stop solution that goes beyond just funding or IP management.

3. Scientific Credibility & Medical Network

• Backed by a Nobel Prize–winning team and clinical research veterans from Harvard, Stanford, and major Chinese medical institutions.
• Strong ties to real-world research and application scenarios, especially in stem cell therapy and biotherapy.

4. Token-Driven Contribution Model

• Introduces a data empowerment model where data contributors, researchers, and institutions are transparently rewarded via $CEL tokens.
• Promotes a sustainable, circular economy within the research ecosystem.

5. Enterprise & Regulatory Readiness

• Designed to comply with privacy regulations (e.g., HIPAA, GDPR) using privacy-preserving tech.
• Positioned for partnerships with hospitals, biotech firms, and research institutions—unlike most DeSci projects that are limited to crypto-native or academic communities.

2. Current User Base and Estimation Method:

Current User Base
CelData is currently in its early launch and ecosystem-building phase. While mass adoption is still in development, it already has a targeted and strategically aligned early community, including:

• Researchers and Academic Partners
  Collaborations are being formed with scientists from global institutions, including those in stem cell and genomics research fields.
• Biotech & Healthcare Institutions
  Strategic dialogues have begun with hospitals, pharmaceutical companies, and data labs in Asia and Europe that require secure, collaborative data infrastructure.
• Web3-Native Developers & Contributors
  The early Web3 community (especially from the DeSci and data DAO verticals) is engaged via hackathons, token incentives, and governance discussions.
• Node Holders & Token Community
  CelData has launched an early node program, with strong uptake among Web3 investors and healthcare innovation supporters, who are incentivized to participate in governance and protocol growth.

3. Estimation Method
   CelData estimates its early and future user base through a tiered approach, combining on-chain data, industry market size, and adoption benchmarks:
   On-Chain Participation Metrics

• Wallet activity from node participants
• Testnet usage and interaction with DID modules, storage APIs, and compute nodes
• Governance proposal participation and token staking volumes

Institutional Outreach Conversion Rate

• Based on current outreach pipeline, CelData anticipates a 10–15% conversion rate from interested institutions to active ecosystem participants (e.g., hospitals, labs, research institutes)

Comparable DeSci Benchmarks

• For reference, projects like VitaDAO and Ocean Protocol attracted 5k–50k users in early phases.
• Given CelData’s vertical focus and added utility in biomedical research, CelData expects to onboard 20k–50k users in its first 12–18 months post-mainnet.

Life Sciences Market Size Mapping

• The global life sciences R&D market is valued at >$300B, with millions of researchers worldwide. Even 0.1% market penetration would translate to tens of thousands of platform users.

Recipient Address

0x5dD01AC1d41943d06f56E0Ba624a05b9Ab2313B6

Budget and Plan

1. Grant Size and Justification
   Requested Grant Size:
   $20,000 USD

Justification: Why This Grant Size Is Strategic and Necessary
CelData is at a critical growth stage where targeted funding can accelerate technical development, expand adoption, and ensure real-world integration. The requested grant will be allocated across 4 strategic pillars, each contributing directly to the success of both CelData and the HashKey ecosystem.

1. Technical Development (40%) – $8,000
   Finalize deployment of mainnet modules for:

• Decentralized storage integrations (e.g., IPFS, Arweave)
• Privacy-preserving computing (MPC / federated learning layer)
• DID identity and access framework
• Build developer SDKs and API gateway for enterprise users.
• Conduct security audits to meet enterprise-grade compliance.

2. Ecosystem Growth & Community Building (30%) – $3,000

• Launch academic partnerships and run pilot programs with at least 3 research institutions.
• Sponsor and participate in global DeSci and life sciences events (e.g., Bio-IT World, ETHGlobal, DeSci.Berlin).
• Expand community ambassador program in Asia-Pacific & EU regions.

3. Marketing & Awareness (20%) – $7,000

• Launch multilingual content campaign (EN/ZH/KR) including:
• Researcher education material
• Project explainers for biotech stakeholders
• Social media and technical blog series
• Run targeted campaigns with DeSci and Web3 influencers to attract early adopters and partners.

4. Testing & Validation (10%) – $2,000

• Run large-scale testnet and data validation challenges with real research datasets (e.g., genomics or clinical trials).
• Recruit scientific validators and data partners to ensure real-world applicability and feedback loop.

Why This Size is Optimal for HashKey

• High Leverage: Funding directly accelerates infrastructure that's hard to bootstrap purely from token issuance.
• Real-World Impact: Ties Web3 funding to practical research and scientific advancement.
• Long-Term Alignment: Builds a sticky, multi-year ecosystem that could serve as a flagship DeSci initiative within HashKey’s portfolio.

2. Project Execution Plan (Roadmap):
   Q2 2025 – Foundation & Technical Development

• Complete Decentralized Storage Integrations: Finalize integration with IPFS and Arweave for scalable and secure data storage.
• Privacy-Preserving Computing Layer: Deploy the MPC and federated learning systems to ensure data privacy in collaborative research.
• Developer SDKs & API Gateway: Launch SDKs and an API gateway to provide seamless integration for enterprise users.
• Security Audits: Conduct rigorous security audits to meet enterprise-grade compliance.

Q3 2025 – Ecosystem Growth & Partnerships

• Launch Academic Partnerships: Establish formal partnerships with 3 key research institutions to run pilot programs.
• Participate in Global DeSci Events: Sponsor and present at Bio-IT World, ETHGlobal, and other key conferences to build visibility in the DeSci community.
• Expand Ambassador Program: Strengthen community engagement and recruit ambassadors in Asia-Pacific & EU regions to build a global ecosystem.
• Listing on Exchange

Q4 2025 – Testing & Validation

• Testnet Launch & Data Challenges: Run large-scale testnets with real research datasets (e.g., genomics, clinical trials) to validate the platform’s capabilities and gather feedback from scientific validators.
• Launch User Feedback Loops: Collect feedback from data partners, research institutions, and early adopters to refine the platform for enterprise deployment.

2026 and Beyond – Scaling & Mainstream Adoption

• Full Mainnet Launch: Transition from testnet to mainnet, allowing full-scale adoption by research institutions, biotech companies, and other enterprise partners.
• Ongoing Community Engagement & Growth: Expand partnerships, continuously improve platform features, and support growing user and developer communities.
• Explore New Use Cases: Expand the platform’s capabilities to support additional life sciences use cases, such as environmental research and clinical applications.

3. Token Distribution (Percentages and Initiatives):
   Node: 15%
   Team: 20%
   Airdrop: 10%
   Ecosystem: 15%
   Foundation: 5%
   Investor: 10%
   Marketing: 5%
   Launchpad: 5%

4. Token Distribution Timeline:
   TBA

5. Post-Incentives Sustainability:

6. Revenue Model:

• Enterprise Solutions: Paid services for biotech companies and research institutions, including storage and privacy-preserving computing.
• Subscription Access: Premium features for researchers via subscription-based access.

2. Tokenomics:

• Native Token & Staking: CelData’s native token will incentivize participation and governance, sustaining platform engagement.
• Decentralized Validation Network: Validators will be rewarded with tokens, ensuring data integrity and platform growth.

3. Partnerships:

• Academic & Research Partnerships: Ongoing collaborations with institutions to drive innovation and usage.
• Cross-Industry Collaborations: Partnerships with Web3 and blockchain projects will open new revenue streams.

4. Continuous Improvement:

• Community-Driven Development: Regular feedback loops, hackathons, and governance proposals will keep the platform competitive.
• Research Grants & Collaborations: Securing funding for research and development initiatives.

5. Expansion & Diversification:

• Sector Expansion: Beyond life sciences, CelData will expand into sectors like healthcare and environmental science.
• Global Community Growth: Continued ambassador and community programs will ensure widespread adoption and engagement.

Hashkey Relationship

1. Problem Solved for Hashkey:
   By supporting CelData, HashKey addresses several critical challenges within the Web3 and decentralized science (DeSci) space:

• Data Privacy and Security in Scientific Research:
  CelData solves the issue of securing sensitive research data, such as genomics or clinical trial information. Through privacy-preserving technologies like MPC and federated learning, CelData enables collaboration without compromising data security, addressing a key concern in research sectors.
• Fragmented Data Sharing Systems:
  The current landscape of scientific data sharing is fragmented and siloed, making it difficult to securely share and validate datasets across institutions. CelData provides a decentralized, transparent platform that facilitates seamless and secure data sharing, breaking down these barriers and improving global collaboration.
• Lack of Blockchain Integration in Life Sciences:
  Despite the potential of Web3, the life sciences and research sectors have been slow to adopt blockchain technology. CelData bridges this gap by applying blockchain solutions to the scientific data management space, demonstrating real-world use cases for Web3 and driving adoption within an industry that historically has been resistant to new technologies.
• Scalability of Decentralized Infrastructure:
  CelData addresses the challenge of scalability by providing a robust infrastructure that supports large datasets and complex computations, essential for life sciences research. This scalability ensures that the platform can grow alongside scientific advancements, offering long-term sustainability.

2. Value Proposition:
   CelData represents a revolutionary step forward in the decentralized science (DeSci) and life sciences sectors by leveraging blockchain technology to enable secure, scalable, and privacy-preserving data management. The platform’s core value proposition is to bridge the gap between cutting-edge scientific research and Web3 technology, allowing researchers and institutions to share, validate, and access high-quality datasets without compromising privacy or security.

Key Value Drivers:

1. Decentralized Data Ownership: CelData enables researchers and institutions to retain control over their data through decentralized storage solutions like IPFS and Arweave. This empowers data creators to securely share datasets while preserving ownership, ensuring they benefit from future use and collaboration.
2. Privacy-Preserving Research: CelData integrates privacy-preserving computing techniques such as MPC (Multiparty Computation) and federated learning, ensuring that sensitive research data, like genomics or clinical trial information, can be analyzed and shared without revealing private information. This unlocks the potential for collaborative research without sacrificing privacy.
3. Open and Transparent Ecosystem: By utilizing blockchain, CelData provides a transparent and immutable audit trail of data exchanges and research collaborations. This not only increases trust but also enhances the reproducibility of scientific experiments, a critical factor for advancing scientific discovery.
4. Empowering Researchers with Tools for Collaboration: Through developer SDKs and APIs, CelData offers seamless integration for both individual researchers and enterprise users. This open infrastructure allows for collaboration across borders, disciplines, and institutions, fostering a global network of scientific progress.
5. Bridging the Gap Between Web3 and Life Sciences: CelData’s mission goes beyond just blockchain technology. By aligning itself with the needs of life sciences and DeSci communities, CelData ensures that Web3 technologies serve as a practical, sustainable solution to real-world challenges in fields like genomics, clinical research, and healthcare.

Strategic Impact:

• Unlocking Global Collaboration: CelData creates a borderless ecosystem for scientific research, where data can be shared, validated, and utilized across borders, unlocking new opportunities for global collaboration in critical scientific fields.
• Accelerating Innovation: By reducing barriers to data access and improving data security, CelData accelerates the pace of innovation in life sciences, enabling faster breakthroughs in areas such as drug discovery, personalized medicine, and environmental science.
• Enabling Sustainability in Research: With decentralized systems in place, CelData not only addresses the technical challenges of data management but also enables more sustainable research practices by ensuring that data remains accessible and usable over the long term.

3. Growth Potential for Hashkey:
   Supporting CelData offers HashKey a strategic opportunity to lead in the rapidly growing DeSci sector, unlocking substantial long-term growth.

• DeSci Leadership: CelData positions HashKey at the forefront of decentralized science, a transformative industry in research and data sharing.
• Ecosystem Expansion: CelData’s partnerships with research institutions and biotech companies will broaden HashKey’s network and influence.
• Real-World Adoption of Web3: CelData’s applications in healthcare and life sciences will accelerate Web3 adoption, driving mainstream use of blockchain technologies.
• Financial Returns: As CelData scales, HashKey stands to gain from network effects and revenue generation through enterprise solutions and partnerships.
• Brand Recognition: HashKey’s early involvement in CelData solidifies its position as a leader in Web3 and DeSci innovation.
• Synergies with Portfolio: CelData complements HashKey’s existing projects, creating opportunities for cross-collaborations and enhanced ecosystem value.

4. Commitment to Building on Hashkey:
   yes

5. Deployment Status:
   Ongoing

Milestones

1. Milestone 1: Technical Development & Mainnet Deployment

Description: Finalize decentralized storage integrations (IPFS, Arweave), privacy-preserving computing (MPC/federated learning), and launch SDKs/API gateway.

Timeline: Q2 2025

2. Milestone 2: Ecosystem Expansion & Academic Partnerships and listing

Description: Establish partnerships with 3 major research institutions, run pilot programs, and expand presence at DeSci events (e.g., Bio-IT World, ETHGlobal). Listing on Exchange

Timeline: Q3 2025

3. Milestone 3: Testnet Launch & Validation with Real Data

Description: Run large-scale testnet with real research datasets (e.g., genomics, clinical trials) and collect feedback from scientific validators.

Timeline: Q4 2025

Terms Confirmation

• I confirm that all information provided is true and accurate
• I understand and agree to comply with the grant policies
• I understand the KYC requirements
• I confirm token distribution complies with legal requirements